Nilutamide

Synonyms: RU23908

Nilutamide (RU23908) is a nonsteroidal antiandrogen (NSAA) with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors). It is used in the treatment of prostate cancer.

Nilutamide Chemical Structure

Nilutamide Chemical Structure

CAS: 63612-50-0

Purity & Quality Control

Batch: S483601 DMSO] 63 mg/mL] false] Ethanol] 63 mg/mL] false] Water] Insoluble] false Purity: 99.19%
99.19

Choose Selective Androgen Receptor Inhibitors

Biological Activity

Description Nilutamide (RU23908) is a nonsteroidal antiandrogen (NSAA) with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors). It is used in the treatment of prostate cancer.
Targets
Androgen Receptor [1]
In Vivo
In vivo Nilutamide has a long half-life which permits once-daily administration. The tolerance of nilutamide is generally acceptable[1].

Chemical lnformation & Solubility

Molecular Weight 317.22 Formula

C12H10F3N3O4

CAS No. 63612-50-0 SDF --
Smiles CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 63 mg/mL ( (198.6 mM); Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 63 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Nilutamide | Nilutamide ic50 | Nilutamide price | Nilutamide cost | Nilutamide solubility dmso | Nilutamide purchase | Nilutamide manufacturer | Nilutamide research buy | Nilutamide order | Nilutamide mouse | Nilutamide chemical structure | Nilutamide mw | Nilutamide molecular weight | Nilutamide datasheet | Nilutamide supplier | Nilutamide in vitro | Nilutamide cell line | Nilutamide concentration | Nilutamide nmr